Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

Google is rolling out AI music generation inside the Gemini app. It's powered by Google's advanced Lyria 3 AI model. You can create music tracks up to 30 seconds using text prompts, images, and even ...

Abstract: Writing comprehensive unit tests is a time-consuming challenge in software development. While Large Language Model (LLM) based tools offer a solution, they often struggle with code ...